Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach

Y Tanaka, Y Luo, JJ O'Shea… - Nature Reviews …, 2022 - nature.com
The four Janus kinase (JAK) proteins and seven signal transducer and activator of
transcription (STAT) transcription factors mediate intracellular signal transduction …

The 'cytokine storm': molecular mechanisms and therapeutic prospects

R Karki, TD Kanneganti - Trends in immunology, 2021 - cell.com
Cytokine storm syndrome (CSS) has generally been described as a collection of clinical
manifestations resulting from an overactivated immune system. Cytokine storms (CSs) are …

Treat-to-target in systemic lupus erythematosus: advancing towards its implementation

AR Parra Sánchez, AE Voskuyl… - Nature reviews …, 2022 - nature.com
The treat-to-target (T2T) concept has improved outcomes for patients with diabetes,
hypertension and rheumatoid arthritis. This therapeutic strategy involves choosing a well …

JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition

Y Luo, M Alexander, M Gadina, JJ O'Shea… - Journal of Allergy and …, 2021 - Elsevier
Since its discovery, the Janus kinase-signal transduction and activation of transcription (JAK-
STAT) pathway has become recognized as a central mediator of widespread and varied …

Bite of the wolf: innate immune responses propagate autoimmunity in lupus

S Gupta, MJ Kaplan - The Journal of clinical investigation, 2021 - Am Soc Clin Investig
The etiopathogenesis of systemic lupus erythematosus (SLE), a clinically heterogeneous
multisystemic syndrome that derives its name from the initial characterization of facial …

Interferon lambda in inflammation and autoimmune rheumatic diseases

RR Goel, SV Kotenko, MJ Kaplan - Nature Reviews Rheumatology, 2021 - nature.com
Interferons are potent antiviral cytokines that modulate immunity in response to infection or
other danger signals. In addition to their antiviral functions, type I interferons (IFNα and IFNβ) …

Why do we need JAK inhibitors in systemic lupus erythematosus?

P Richter, A Cardoneanu, AM Burlui… - International Journal of …, 2022 - mdpi.com
Systemic lupus erythematosus (SLE) is a chronic, multifactorial autoimmune disease with
complex pathogenesis characterized by the imbalance of pro-inflammatory and anti …

A systematic review of clinical and preclinical evidences for Janus kinase inhibitors in large vessel vasculitis

U Rathore, DR Thakare, P Patro, V Agarwal… - Clinical …, 2022 - Springer
Corticosteroid-sparing disease-modifying anti-rheumatic drugs are an area of active
exploration in large vessel vasculitis (LVV), ie, Takayasu arteritis (TAK) and Giant Cell …

Эффективность и безопасность тофацитиниба при иммуновоспалительных ревматических заболеваниях (часть I)

ЕЛ Насонов, АС Авдеева, АМ Лила - Научно-практическая …, 2020 - cyberleninka.ru
Расшифровка механизмов патогенеза иммуновоспалительных ревматических
заболеваний (ИВРЗ) в сочетании с разработкой широкого спектра генно-инженерных …

HIPPOCRATES: improving diagnosis and outcomes in psoriatic arthritis

O FitzGerald, SR Pennington - Nature Reviews Rheumatology, 2022 - nature.com
Combining the diverse expertise of clinical and scientific researchers from across Europe as
well as patient representatives and pharmaceutical industry partners, the HIPPOCRATES …